Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 881

Results For "C"

9089 News Found

Lupin Mandideep plant gets USFDA green signal
Drug Approval | November 01, 2023

Lupin Mandideep plant gets USFDA green signal

The inspection of the facility conducted from August 7 to August 11, 2023


Ayurveda benefits animal, plant and human life, says Sonowal
News | October 11, 2023

Ayurveda benefits animal, plant and human life, says Sonowal

Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush


Mitsui invests in Lokavant Holdings
News | October 09, 2023

Mitsui invests in Lokavant Holdings

Lokavant provides clinical trial intelligence


Alkem rolls out patient awareness drive under its breathe initiative
News | September 28, 2023

Alkem rolls out patient awareness drive under its breathe initiative

Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India


27,353 hospitals empanelled under PM-JAY
Policy | September 26, 2023

27,353 hospitals empanelled under PM-JAY

30 beneficiaries avail of services per minute


Arogya Manthan 2023 to mark 5 years of Ayushman Bharat PM-JAY
Policy | September 25, 2023

Arogya Manthan 2023 to mark 5 years of Ayushman Bharat PM-JAY

National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi


Natural Biogenex performs inauguration at Tumkur unit
News | September 22, 2023

Natural Biogenex performs inauguration at Tumkur unit

This production block consists of chemical synthesis reactions and clean rooms areas to produce final API


Jupiter Life Line Hospitals lists at 32.38% premium
News | September 20, 2023

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy